Medtronic Launches CGM-Integrated Smart Insulin Pen For Multiple Daily Injections

The announcement follows Medtronic’s acquisition of Companion Medical, which developed the first FDA-cleared insulin smart pen.

MT2008_Stop Diabetes_1056829304_1200.jpg

Three months after Medtronic plc announced the acquisition of insulin-pen maker Companion Medical as part of its efforts to bolster its diabetes business, it is getting ready to launch the InPen and integrate it with its Guardian Connect continuous glucose monitoring (CGM) system.

Customers that have the InPen and Guardian Connect can integrate the two starting 12 November by downloading the newest version...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight

Dxcover Launches US Operations With New Headquarters In Tennessee

 

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

EnsoData Boosts AI Sleep Tech With $20M Series B Funding, Targets Underdiagnosis Crisis

 
• By 

EnsoData positions itself as device-agnostic and interoperable, with FDA-cleared software that can integrate with all major devices. CEO Mortara said this flexibility helps maximize patient reach by enabling both direct provider engagement and integration with device manufacturers.

FDA Blocks Some Olympus Endoscopes From Entering US

 

After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.